Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01376375 · ClinicalTrials.gov registry record · Phase 1
Acupuncture to Reduce Signs of Inflammation in Participants With Chronic Low Back Pain
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT01376375: Completed Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT01376375 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 5 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01376375, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
Background: \- Acupuncture is a traditional Chinese medical treatment. Thin needles are used to stimulate specific points in the body. Previous studies have found that acupuncture can be useful in treating low back pain. This study will explore how acupuncture affects low back pain. Researchers will look at blood samples for changes in different chemicals related to inflammation and pain. Objectives: \- To test the effect of acupuncture on blood chemicals associated with chronic low back pain. Eligibility: * People at least 18 years of age who have chronic low back pain. * Those who have had back surgery or had acupuncture for any medical condition may not participate. Design: * This study requires eight visits over 2 to 3 weeks. Each visit will take 1.5 to 2 hours. * At the first study visit, participants will give a medical history and complete two questionnaires about their low back pain. They will also spend 30 minutes lying down on a bed, relaxing quietly. * The next visits will occur every 2 to 3 days for the next 2 weeks. Participants will receive 30 minutes of either sham or standard acupuncture. Sham acupuncture will mimic the standard procedure, but no needles will be used. The standard procedure will be performed in the same location. A licensed, experienced acupuncturist will insert small disposable needles into acupuncture sites on the back, arms, and legs. Those in the study will not know whether they are receiving the sham or the standard acupuncture procedure. * At some visits, participants will provide blood samples for testing. At every visit, participants will complete the questionnaires about low back pain.
Interventions
- PROCEDURE Acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-06-10 |
| Est. Completion | 2013-04-26 |
| Phase | Phase 1 |
What the finished NCT01376375 record still lists
NCT01376375 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Acupuncture is the first listed.
NCT01376375 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01376375 about?
NCT01376375 is a clinical study titled "Acupuncture to Reduce Signs of Inflammation in Participants With Chronic Low Back Pain". Background: \- Acupuncture is a traditional Chinese medical treatment. Thin needles are used to stimulate specific points in the body. Previous studies have found that acupuncture can be useful in treating low back pain. This study will explore how acupuncture affects low back pain. Researchers wil...
What is the current status of trial NCT01376375?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2011-06-10. Estimated completion is 2013-04-26.
What interventions are being tested in trial NCT01376375?
The interventions under investigation include: Acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT01376375?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01376375's enrollment target sits among peer trials
5 1989th of 2000 higher than 6 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI